Neuroendocrine tumors are often recorded in the gastrointestinal tract or lungs, however head and neck are a rare site, the larynx is the commonest site in this anatomic region.
Although primary neuroendocrine carcinomas are the most common neoplasm of larynx in non-squamous category, its incidence is very low (
9).
Neuroendocrine tumors of the larynx are classified as well-differentiated neuroendocrine carcinoma: typical carcinoid; moderately differentiated neuroendocrine carcinoma: atypical carcinoid tumor; poorly differentiated neuroendocrine carcinoma: large and small cell neuroendocrine carcinoma and Paragangliomas that are neuroendocrine tumors with neural origin (
2,
4). However, some authors considered laryngeal large cell neuroendocrine carcinoma as a separate entity due to its aggressive behavior (
6-
10).
Typical carcinoids are very rare, while atypical carcinoid tumors are more frequent and had aggressive character (
3). They usually metastasis to lymph nodes, bone, skin, liver, and lung (
7,
11).
Atypical carcinoid is the most common neuroendocrine tumors of the larynx that represents 0.2% - 0.6% of laryngeal malignancies (
3,
5) laryngeal atypical carcinoid was first described by Goldman et al. in1969 (
9).
Atypical carcinoid tumors of the larynx occur in heavy smokers in their 60s and the ratio in male to female is 3:1 (
5). These tumors mostly occur in supraglottis (90% of cases). The most common locations are aryepiglottic fold, arytenoid, and epiglottis (
12). The presenting symptoms varied according to the location and compose of hoarseness, dysphagia, pharyngodynia, hemoptysis, and dyspnea (
13).
Pathological features include nests of monomorphic cells with round nuclei and speckled chromatin, occasionally moderate atypia may be present (
4). In neuroendocrine carcinomas, immunohistochemical study shows a positive result for chromogranin, synaptophysin, a cluster of differentiation (CD) 56, and neural cell adhesion molecule (NCAM) (
14).
The recommended management is complete surgical removal with partial or total laryngectomy according to tumor size and extension. Since there is a high probability of cervical lymph nodes involvement, bilateral elective neck dissection should be performed. According to some references, limited dissection of level IIA and level III is enough for patients with no clinical lymphadenopathy. This tumor is reported to be resistant to both radiotherapy and chemotherapy. However, radiotherapy may be valuable if the tumor is locally extended or lymph node involvement is proved (
2). Radiotherapy or chemotherapy is less effective and should be reserved for special situations (
9). For atypical carcinoid tumors of the larynx, the 5-year survival rate reported being approximately 46.7% (
11).
The clinical symptoms in our cases were not different from the usual presentations of neuroendocrine carcinomas of the larynx, but both cases were non-smoker females. The primary tumor locations were supraglottis as expected. The second case was more aggressive with extension to the glottis. An unusual finding in the first case was the indolent course of disease. She had a one-year history of the symptom without local extension or regional metastasis despite being an atypical carcinoid. Pathologic findings were typically being positive for Chromogranin, Ki67, creatine kinase AE/3, and neuron-specific enolase (NSE). Although distant metastasis is common in neuroendocrine tumors of the larynx, our cases had no distant metastasis.
3.1. Conclusions
A typical carcinoid tumor is an underdiagnosed malignancy. They can unexpectedly occur in none-smoker women. Although neuroendocrine tumor of the larynx is actually rare, physicians should be familiar with its unspecified presentations, pathology, clinical course, and prognosis.